Health Condition 1: C50- Malignant neoplasm of breast Health Condition 2: D- Radiation Therapy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Subjects with a confirmed diagnosis of Breast cancer patients, stage I to III, scheduled to undergo radiotherapy, ECOG-PS: 0 to 2 or KPS score more than 70, who are willing to give consent and participate in the 12-week intervention study protocol for hybrid-online and offline mode
Exclusion criteria
Exclusion criteria: Subjects with Stage IV breast cancer with Metastasis, Patient planned for Brachytherapy, Neo-adjuvant Chemo with radiotherapy, currently doing another form of structured yoga, Severe medical co-morbidities, inability to perform yoga, Pregnant women, those who are on medication for severe psychotic diseases, Severe immobility due to arthritis, vision, and hearing impairment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| EORTC 42 (Quality of life), HADS (Anxiety and Depression Score), PSS (Perceived Stress score), PSQI (Pittsburgh Sleep Quality score), treatment-related symptoms(VAS Score), Prakruti -vikruti questionnaire, Nadipariksha score Timepoint: Timepoints: T1=Baseline (prior to start of radiation therapy) T2= End of radiation therapy (approx. 6 weeks from baseline) T3= 12 weeks from baseline EORTC 42:T1.T2,T3, HADS:T1.T2,T3, PSS:T1,T2,T3, PSQI:T1T2T3, symptoms(VAS Score): T1,T2,T3, Prakruti -vikruti Priksha: T1,T2 Nadipariksha: daily between T1 and T2 | — |
Secondary
| Measure | Time frame |
|---|---|
| Hear Rate Variability (HRV )Timepoint: T1,T2 | — |
Countries
India
Contacts
Dr.Vishwanath Karad MIT World Peace University